InsiderTrades

Form 4 for SNDX Syndax Pharmaceuticals Inc

Accepted 2023-08-03 00:00:00 ET · period of report 2023-08-02 · accession 0001562180-23-006130 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2023-08-03 2023-08-02 SNDX Meury William Dir S - Sale+OE $20.46 -83.0K 48.0K -63% -$1.70M
DMT 2023-08-03 2023-08-02 SNDX Meury William Dir M - OptEx $8.02 +83.0K 72.0K New +$665.2K
DMT 2023-08-03 2023-08-02 SNDX Meury William Dir M - OptEx $0.00 -83.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-02 S D 24,000 $20.45 48,000 D — — (F3) The sale prices ranged from $20.2950 to $20.89.
2 Common Common Stock 2023-08-02 M A 35,000 $7.11 83,000 D — —
3 Common Common Stock 2023-08-02 M A 24,000 $9.47 72,000 D — —
4 Common Common Stock 2023-08-02 S D 24,000 $20.46 48,000 D — — (F2) The sale prices ranged from $20.30 to $20.97.
5 Common Common Stock 2023-08-02 M A 24,000 $7.88 72,000 D — —
6 Common Common Stock 2023-08-02 S D 35,000 $20.46 48,000 D — — (F1) The sale prices ranged from $20.29 to $21.00.
7 Derivative Stock Options (Right to buy) 2023-08-02 M D 24,000 $0.00 0 D $9.47 · — to 2030-02-12 24,000 Common Stock (F4) This option is fully vested.
8 Derivative Stock Options (Right to buy) 2023-08-02 M D 35,000 $0.00 0 D $7.11 · — to 2028-09-25 35,000 Common Stock (F4) This option is fully vested.
9 Derivative Stock Options (Right to buy) 2023-08-02 M D 24,000 $0.00 0 D $7.88 · — to 2029-06-10 24,000 Common Stock (F4) This option is fully vested.